Legal Advantage Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Legal Advantage Investments's XBI Position: Q1 2025 in Review
Legal Advantage Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 19,965 shares — an estimated $1.8M sold.
Legal Advantage Investments first reported a position in XBI in Q4 2020 and held it in 17 quarters. The position peaked at $2.84M in Q4 2020. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- Legal Advantage Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- Legal Advantage Investments sold 19,965 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.8M.
- Legal Advantage Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 17 quarters.
- Legal Advantage Investments's State Street SPDR S&P Biotech ETF position peaked at $2.84M in Q4 2020.
- 683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on Legal Advantage Investments's 13F filing for Q1 2025, filed 13 May 2025.